Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Parkinson Disease: HELP
Kenneth Marek
Based on 60 articles published since 2010
(Why 60 articles?)
||||
Expertise Level
The expertise of Kenneth Marek ranks in the
  • Top 0.55%
  • ... of 89,464 published authors worldwide on Parkinson Disease
  • ... from 2010 through 2020
  • ... based on contributions to 60 articles on the topic.
Graphical view (beta)
Get your prestigious
Expert badge
similar to this:
 
Aliases Marek, Ken   ·   Marek, Kenneth
Work Locations
Details
Most likely:    Miscellaneous institutions in New Haven      
2020
  • University of Pittsburgh, Pittsburgh, PA, USA. · Blackfynn, Philadelphia, PA, USA. · University of Iowa, Iowa City, IA, USA. · University of Alabama at Birmingham, Birmingham, AL, USA. · University of California, and San Francisco Veterans Affairs Medical Care Plan, San Francisco, CA, USA. · The Michael J. Fox Foundation for Parkinson's Research, New York, NY, USA. · Rutgers, The State University of New Jersey, Piscataway, NJ, USA. · University of Rochester, Rochester, NY, USA. · Theravance Biopharma, San Francisco, CA, USA. · 23and Me Inc., Mountain View, CA, USA. · Institute for Neurodegenerative Disorders, New Haven, CT, USA. · Toronto Western Hospital, Toronto, Canada. · Pubmed 31958097
2019
  • Department of Neurology, University of Pittsburgh, Pittsburgh, PA, USA. · Departments of Neurology Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. · Department of Biostatistics, College of Public Health, University of Iowa, Iowa City, IA, USA. · Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA. · Department of Neurology, University of California, San Diego, CA, USA. · Department of Neurology, University Medical Center Goettingen, Goettingen, Germany and Paracelsus-Elena-Klinik, Kassel, Germany. · The Michael J. Fox Foundation, New York, NY, USA. · Institute for Neurodegenerative Disorders, New Haven, CT, USA. · Department of Neurology, University of California San Francisco, San Francisco, CA, USA. · Department of Neurology, University of Rochester Medical Center, Rochester, NY, USA. · Pubmed 31450510
  • Department of Neurology, University Medical Center Goettingen, Göttingen, Germany; and Paracelsus-Elena Klinik, Kassel, Germany. · Department of Biostatistics, College of Public Health, University of Iowa, Iowa City, Iowa, USA. · BioLegend Inc., San Diego, California, USA. · Molecular Genetics Section, Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, Maryland, USA. · Department of Pathology & Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA. · Center for Neurodegenerative Disease Research, Institute on Aging, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA. · Morris K. Udall Center of Excellence for Parkinson's Disease Research, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA. · The Michael J. Fox Foundation for Parkinson's Research, New York, New York, USA. · Parkinson's Disease and Movement Disorders Center, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA. · Neurological Service, Hospital Clinic de Barcelona, Barcelona, Spain. · Department of Neurology, Philipps University Marburg, Marburg, Germany. · Department of Neurology Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA. · Institute for Neurodegenerative Disorders, New Haven, Connecticut, USA. · University of Southern California, Laboratory of Neuro Imaging, Los Angeles, California, USA. · Department of Neurology, University of California San Francisco, San Francisco, California, USA. · Clinical Trials Coordination Center, University of Rochester Medical Center, Rochester, New York, USA. · Department of Neurology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA. · Department of Neurosciences, University of California, San Diego, San Diego, California, USA. · Pubmed 31361367
2018
  • Department of Neurology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104, USA. · Neurology Service and GRECC, VAAHS, Ann Arbor, MI 48105, USA. · Department of Neurology, University of Michigan, Ann Arbor, MI 48109, USA. · Department of Neurology, Columbia University Medical Center, New York, NY 10032, USA. · National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20824, USA. · Verily/Google Life Sciences, South San Francisco, CA 94080, USA. · Department of Biostatistics, Mailman School of Public Health, Columbia University, New York, NY 10032, USA. · Human Metabolome Technology-America, Boston, MA 02134, USA. · Biogen, Cambridge, MA 02142, USA. · Caprion Biosciences, Montreal, Quebec H2X 3Y7, Canada. · Cell Biology and Gene Expression Section, Laboratory of Neurogenetics, National Institute of Aging, National Institutes of Health, Bethesda, MD 20892, USA. · Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA. · Department of Neurology and Neurotherapeutics, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA. · Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN 46202, USA. · The Michael J. Fox Foundation for Parkinson's Research, New York, NY 10163, USA. · Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA. · Department of Neurology, Penn State University-Hershey Medical Center, Hershey, PA 17033, USA. · Pharmaceutical Research and Early Development, NORD Discovery and Translational Area, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., 4070 Basel, Switzerland. · Institute for Neurodegenerative Disorders, New Haven, CT 06510, USA. · Departments of Cancer Biology and Pathology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA. · Blais Proteomics Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA. · Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02215, USA. · Chaperone Therapeutics, Portland, OR 97229, USA. · Paracelsus-Elena-Klinik, 34128 Kassel, Germany. · University Medical Center, 37075 Goettingen, Germany. · Department of Cellular and Molecular Pharmacology, Chicago Medical School, Rosalind Franklin University of Medicine and Science, Chicago, IL 60064, USA. · Department of Neurology, Johns Hopkins School of Medicine, Baltimore, MD 21205, USA. · Department of Neurology, Mount Sinai Beth Israel, Icahn School of Medicine at Mount Sinai, New York, NY 10003, USA. · Center for Advanced Parkinson's Disease Research and Precision Neurology Program, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. · Laboratory of Neurogenetics, National Institute on Aging, Bethesda, MD 20892, USA. · Luxembourg Centre for Systems Biomedicine, University of Luxembourg, Luxembourg, Luxembourg. · Genentech, San Francisco, CA 94080, USA. · Neurogenomics Division, Translational Genomics Research Institute, Phoenix, AZ 85004, USA. · Department of Applied Physiology, Biomedical Engineering, and Neurology, University of Florida, Gainesville, FL 32611, USA. · Department of Neurology, University of Alabama, Birmingham, AL 35233, USA. · Department of Pathology, University of Washington, Seattle, WA 98195, USA. · Pubmed 30111645
  • 1st Neurology Clinic, Eginition Hospital, Athens University Medical School, Athens, Greece. · 2nd Neurology Clinic, Attikon Hospital, Athens University Medical School, Athens, Greece. · Nuclear Medicine Unit, Attikon Hospital, Athens, Greece. · Neurology Clinic, Henry Dunan Hospital, Athens, Greece. · Institute for Neurodegenerative Disorders, New Haven, Connecticut, USA. · Neurology Clinic, Philipps University, Marburg, Germany. · Parkinson's Disease and Movement Disorders Department, HYGEIA Hospital, Athens, Greece. · Pubmed 30288781
  • Department of Neurology, Christian-Albrechts-University of Kiel, Kiel, Germany. · Department of Neurodegeneration, Hertie-Institute for Clinical Brain Research, Tübingen, Germany. · The Parkinson's Disease and Movement Disorders Center, Department of Neurology, Mayo Clinic, Scottsdale, Arizona, USA. · Department of Neurology, Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Nijmegen, Netherlands. · Xuanwu Hospital of Capitol of Medical University, Beijing, Peoples Republic of China. · Rush University Medical Center, Chicago, Illinois, USA. · Neuroscience Research Australia & University of New South Wales, Randwick, Australia. · Edmond J. Safra Program in Parkinson's Disease and the Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, Toronto, Ontario, Canada. · Brain and Mind Centre University of Sydney, Camperdown, Australia. · German Center for Neurodegenerative Diseases, Tübingen, Germany. · Department of Neurosciences, University of California San Diego, La Jolla, California, USA. · Institute for Neurodegenerative Disorders, New Haven, Connecticut, USA. · University of Navarra-Fundación para la Investigación Médica Aplicada (FIMA), Pamplona, Spain. · Department of Neurology, Philipps University of Marburg, Marburg, Germany. · Department of Neurology, Mount Sinai School of Medicine, New York, New York, USA. · Department of Neurology, Innsbruck Medical University, Innsbruck, Austria. · Department of Neurology, Montreal General Hospital, Montreal, Quebec, Canada. · Penn Neurological Institute, Philadelphia, Pennsylvania, USA. · University of California, San Francisco, California, USA. · Pubmed 30145841
  • Department of Pathology, Peking University Health Science Centre and Third Hospital, Beijing 100191, China; Department of Pathology, University of Washington School of Medicine, Seattle, WA 98104-2499, USA. · Department of Pathology, University of Washington School of Medicine, Seattle, WA 98104-2499, USA. · Department of Biostatistics, University of Washington, Seattle, Washington, USA. · The institute for Neurodegenerative Disorders, New Haven, CT, USA. · University of Aarhus, DANDRITE-Danish Research Institute of Translational Neuroscience & Department of Biomedicine, Aarhus, Denmark. · Department of Pathology, Peking University Health Science Centre and Third Hospital, Beijing 100191, China; Department of Pathology, University of Washington School of Medicine, Seattle, WA 98104-2499, USA. Electronic address: · Pubmed 29705185
  • Northwestern University, Chicago, Illinois, USA. · University of Pennsylvania, Philadelphia, Pennsylvania, USA. · Institute for Neurodegenerative Disorders, New Haven, Connecticut, USA. · University of Iowa, Iowa City, Iowa, USA. · Eli Lilly, Indianapolis, Indiana, USA. · University of California, San Francisco, California, USA. · National Institute on Aging, National Institutes of Health, Bethesda, Maryland, USA. · Clinical Trials Coordination Center, University of Rochester, Rochester, New York, USA. · University of Southern California, Los Angeles, California, USA. · Paracelsus-Elena Klinik, Kassel, Germany. · University of California, San Diego, California, USA. · Indiana University, Indianapolis, Indiana, USA. · Stanford University Medical Center, Stanford, California, USA. · Michael J Fox Foundation, New York, NY, USA. · Pubmed 29572948
  • Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA. · Department of Biostatistics, University of Iowa, Iowa City, Iowa, USA. · University of Pennsylvania School of Medicine and the Parkinson's Disease and Mental Illness Research, Education and Clinical Centers (PADRECC and MIRECC), Philadelphia Veterans Affairs Medical Center, Philadelphia, Pennsylvania, USA. · Center of Parkinsonism and Movement Disorders Paracelsus-Elena Klinik Kassel, University Medical Center Goettingen, Kassel, Germany. · Institute for Neurodegenerative Disorders, New Haven, Connecticut, USA. · University of California San Francisco, San Francisco, California, USA. · Eli Lilly and Company, Indianapolis, Indiana, USA. · University of Rochester Medical Center, Rochester, New York, USA. · University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA. · Pubmed 28986467
  • Critical Path Institute, Tucson, Arizona, USA. · Pfizer Inc, Groton, Connecticut, USA. · Merck Sharp & Dohme, North Wales, Pennsylvania, USA. · UCB, Brussels, Belgium. · Eli Lilly, Indianapolis, Indiana, USA. · University of Arizona, Tucson, Arizona, USA. · Institute for Neurodegenerative Disorders, New Haven, Connecticut, USA. · Pubmed 28749580
2017
  • a Parkinson's Disease and Movement Disorders Center of Boca Raton , FL , USA. · b Saint Luke's Marion Bloch Neuroscience Institute , Kansas City , MO , USA. · c Hackensack University Medical Center, Movement Disorders Center , Hackensack , NJ , USA. · d Irvine Health Movement Disorders Program , University of California , Irvine , CA , USA. · e Thomas Jefferson University, Sidney Kimmel Medical College , Philadelphia , PA , USA. · f University of Southern California Keck School of Medicine , Los Angeles , CA , USA. · g Institute for Neurodegenerative Disorders , New Haven , CT , USA. · h University of Kansas Medical Center , Kansas City , KS , USA. · Pubmed 27813429
  • Institute for Neurodegenerative Disorders, New Haven, Connecticut. · Avid Radiopharmaceuticals, Philadelphia, Pennsylvania. · Pubmed 29114721
  • Department of Neurology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA. · Department of Psychiatry, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA. · PD Research, Education and Clinical Center, Philadelphia Veterans Affairs Medical Center, Philadelphia, Pennsylvania, USA. · Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA. · Department of Biostatistics and Computational Biology, University of Rochester Medical Center, Rochester, New York, USA. · The Institute for Neurodegenerative Disorders, New Haven, Connecticut, USA. · Eli Lilly and Company, Indianapolis, Indiana, USA. · Pubmed 29063713
  • From the Department of Neurology (B.M.), University Medical Center, Göttingen · Paracelsus-Elena-Klinik (B.M.), Kassel, Germany · Department of Biostatistics (C.J.C.-G., C.S.C.), College of Public Health, University of Iowa, Iowa City · BioLegend Inc. (P.T.), San Diego, CA · Department of Pathology & Laboratory Medicine (L.M.S., J.Q.T.), Center for Neurodegenerative Disease Research, Institute on Aging (L.M.S. , J.Q.T.), and Morris K. Udall Center of Excellence for Parkinson's Disease Research (J.Q.T.), Perelman School of Medicine, University of Pennsylvania, Philadelphia · Molecular Genetics Section (A.S.), Laboratory of Neurogenetics, National Institute on Aging, NIH, Bethesda, MD · The Michael J. Fox Foundation for Parkinson's Research (M.F.), New York, NY · Institute for Neurodegenerative Disorders (K.M.), New Haven, CT · and Department of Neurosciences (D.G.), University of California, San Diego. · Pubmed 29030452
  • Parkinson's Disease Research, Education, and Clinical Center (PADRECC), Philadelphia VA Medical Center, Philadelphia, Pennsylvania, USA. · Department of Neurology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA. · Department of Biostatistics and Epidemiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA. · Institute for Neurodegenerative Disorders, New Haven, Connecticut, USA. · Parkinson's Associated Risk Study, New Haven, Connecticut, USA. · Eli Lilly and Company, New York, New York, USA. · Pubmed 28906025
  • GNS Healthcare, Cambridge, Massachusetts, United States of America. · Novartis, Cambridge, Massachusetts, United States of America. · Alexion Pharmaceuticals, Cambridge, Massachusetts, United States of America. · University of Rochester, Rochester, New York, United States of America. · Morton and Gloria Movement Disorders Clinic and the Edmond J. Safra Program in Parkinson's Disease, Toronto Western Hospital and the University of Toronto, Toronto, Ontario, Canada. · Institute for Neurodegenerative Disorders, New Haven, Connecticut, United States of America. · Georgetown University, Washington, DC, United States of America. · National Institute on Aging, NIH, Bethesda, Maryland, United States of America. · University of San Francisco & San Francisco Veterans Affairs Medical Center, San Francisco, California, United States of America. · Biogen Idec, Cambridge, Massachusetts, United States of America. · Voyager Therapeutics, Cambridge, Massachusetts, United States of America. · Pubmed 28604798
  • Institute for Neurodegenerative Disorders, New Haven, Connecticut. · Avid Radiopharmaceuticals, Philadelphia, Pennsylvania. · Parkinson's Disease and Movement Disorders Center, Department of Neurology, University of Pennsylvania, Philadelphia. · Department of Biostatistics and Computational Biology, University of Rochester, Rochester, New York. · Pubmed 28595287
  • Department of Neurology, The University of Alabama at Birmingham, Birmingham, Alabama, USA. · Department of Neurology, The University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA. · Department of Biostatistics, The University of Iowa, Iowa City, Iowa, USA. · Department of Neurology, Innsbruck Medical University, Innsbruck, Austria. · Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts, USA. · Neurology Service, Hospital Clinic de Barcelona, IDIBAPS, CIBERNED, Barcelona, Spain. · Department of Neurology, Hephata-Klinik, Hephata Hessisches Diakoniezentrum, e.V., Schwalmstadt-Treysa, Germany. · Cleveland Clinic Neurological Institute, Cleveland, Ohio, USA. · Division of Neurology, McGill University, Montreal, Québec, Canada. · Department of Neurology, Philipps University, Marburg, Germany. · Charitable Hertie Foundation, Frankfurt, Germany. · Institute for Neurodegenerative Disorders, New Haven, Connecticut, USA. · Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA. · Pubmed 28554959
  • Parkinson's Disease and Movement Disorders Unit, Neurology Service, Hospital Clinic de Barcelona, Universitat de Barcelona, Institut d'Investigacions Biomediques August Pi I Sunyer (IDIBAPS), Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Barcelona, Spain. · Neurology Unit, Hospital General de Granollers, Universitat Internacional de Catalunya, Granollers, Spain. · Department of Biostatistics, College of Public Health, University of Iowa, Iowa City, Iowa, USA. · Department of Neurology, College of Physicians and Surgeons, Columbia University, New York, New York, USA. · Departments of Neurology and Neurobiology, Xuanwu Hospital of Capital Medical University, Beijing, China. · Parkinson's Disease Research, Education and Clinical Center, Michael J. Crescenz VA Medical Center and Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA. · The Michael J. Fox Foundation for Parkinson's Research, New York, New York, USA. · Laboratory of Neurodegenerative Disorders, Department of Neurology, Hospital Clínic of Barcelona, Institutd'InvestigacionsBiomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, and the Centre for Networked Biomedical Research on Neurodegenerative Diseases (CIBERNED), Madrid, Spain. · Institute for Neurodegenerative Disorders and Molecular NeuroImaging, New Haven, Connecticut, USA. · Department of Nuclear Medicine, Hospital Clinic de Barcelona, Universitat de Barcelona, Institut d'Investigacions Biomediques August Pi I Sunyer (IDIBAPS), Barcelona, Spain. · Toronto Western Hospital Morton and Gloria Shulman Movement Disorders Centre and the Edmond J. Safra Program in Parkinson's Disease, University of Toronto, Toronto, Ontario, Canada. · Department of Neurology, Movement Disorders Unit. Hospital Universitario Donostia. Biodonostia Research Institute, Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), San Sebastián, Guipúzcoa, Spain. · Department of Neurology, Mount Sinai Beth Israel Medical Center and Icahn School of Medicine at Mount Sinai, New York, New York, USA. · Department of Neurology, Norwegian University of Science and Technology, Trondheim, Norway. · Pubmed 28370517
2016
  • Atlantic Neuroscience Institute Summit New Jersey USA. · Voyager Therapeutics Cambridge Massachusetts USA. · Department of Biostatistics and Computational Biology University of Rochester Rochester New York USA. · Toronto Western Hospital Toronto Ontario Canada. · The Parkinson's Institute Sunnyvale California USA. · Institute for Neurodegenerative Disorders New Haven Connecticut USA. · Columbia University New York New York USA. · Parkinson's Disease Foundation New York New York USA. · Georgetown University Washington District of Columbia USA. · Pubmed 30363507
  • Department of Neurology, Montreal General Hospital, Montreal, Quebec, Canada. · Department of Neurodegeneration, Hertie-Institute for Clinical Brain Research and German Center for Neurodegenerative Diseases, Tuebingen, Germany. · Penn Neurological Institute, Philadelphia, Pennsylvania, USA. · Department of Neurology, Innsbruck Medical University, Innsbruck, Austria. · Department of Neurology, The Mount Sinai Hospital, New York, New York, USA. · Department of Neurology, Philipps University of Marburg, Marburg, Germany. · Institute for Neurodegenerative Disorders, New Haven, Connecticut, USA. · Department of Neurosciences, UC San Diego, La Jolla, California, USA. · Division of Neurology, Toronto Western Hospital, Toronto, Ontario, Canada. · Neuroscience Research Australia & University of NSW, Randwick, Australia. · Rush University Medical Center, Chicago, Illinois, USA. · Hopital De La Salpetriere, Paris, France. · Xuanwu Hospital of Capitol of Medical University, Beijing, People's Republic of China. · Department of Neurology, Radboud university medical center, Donders Institute for Brain, Cognition and Behaviour, Nijmegen, Netherlands. · The Parkinson's Disease and Movement Disorders Center, Department of Neurology, Mayo Clinic, Scottsdale, Arizona, USA. · Department of Neurology, Christian-Albrechts University, Kiel, Germany. · Pubmed 27666574
  • Neurology Parkinson's Disease and Movement Disorders Center Northwestern University Chicago Illinois. · University of Iowa iowa City Iowa. · Clinical Trials Statistical & Data Management Center University of Iowa College of Public Health iowa City iowa. · Institute for Neurodegenerative Disorders (IND) Molecular NeuroImaging LLC (MNI) New Haven Connecticut. · Neurology University of California San Francisco California. · Center for Human Experimental Therapeutics University of Rochester Rochester New York. · Pubmed 27386498
  • Department of Neurology Perelman School of Medicine at the University of Pennsylvania Philadelphia Pennsylvania. · Department of Biostatistics and Epidemiology Perelman School of Medicine at the University of Pennsylvania Philadelphia Pennsylvania. · Department of Psychiatry Perelman School of Medicine at the University of Pennsylvania Philadelphia Pennsylvania. · Parkinson's Associated Risk Study New Haven, CT USA; Institute for Neurodegenerative Disorders New Haven Connecticut. · Department of Neurology Perelman School of Medicine at the University of Pennsylvania Philadelphia Pennsylvania; Parkinson's Associated Risk Study New Haven, CT USA. · Avid Radiopharmaceuticals Philadelphia Pennsylvania. · Department of Pathology and Laboratory Medicine Perelman School of Medicine at the University of Pennsylvania Philadelphia Pennsylvania. · Pubmed 27231704
  • Parkinson's Disease and Movement Disorders Unit, Neurology Service, Institut de Neurociències Hospital Clínic, University of Barcelona, Catalonia, Spain. · Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA. · BioLegend Inc, Dedham, Massachusetts, USA. · Department of Neurodegenerative Diseases and Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany. · Department of Neuroscience, Norwegian University of Science and Technology, Trondheim, Norway. · Department of Neurology, St. Olav's Hospital, Trondheim, Norway. · Morton and Gloria Shulman Movement Disorders Centre and the Edmond J Safra Program in Parkinson's Disease, Toronto Western Hospital, Toronto, Ontario, Canada. · Biostatistics and Data Management Core Facility, IDIBAPS (Hospital Clinic), Barcelona, Spain. · Biostatistics Unit, Faculty of Medicine, Universitat Autònoma de Barcelona, Catalonia, Spain. · Institute for Neurodegenerative Disorders, New Haven, Connecticut, USA. · Centro en Red para la Investigación de Enfermedades Neurodegenerativas CIBERNED, Spain. · Pubmed 27041685
  • Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, 7.103 Founders Pavilion 3400 Spruce Street, Philadelphia, PA, 19104, USA. · Department of Pharmacology, Hypoxia-related Disease Research Center, Inha University School of Medicine, Incheon, Republic of Korea. · Paracelsus-Elena Klinik, Kassel, Germany. · Department of Neuropathology and Neurosurgery, University Medical Center Goettingen, Göttingen, Germany. · Department of Biostatistics, College of Public Health, University of Iowa, Iowa City, IA, USA. · Center for Neurodegenerative Disease Research, Institute on Aging, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. · Department of Neurology, Morris K. Udall Center of Excellence for Parkinson's Disease Research, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. · Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. · Department of Veterans Affairs, Philadelphia, PA, USA. · Department of Neurosciences, University of California, San Diego, CA, USA. · BioLegend Inc., Dedham, MA, USA. · The Michael J. Fox Foundation for Parkinson's Research, New York, NY, USA. · Institute for Neurodegenerative Disorders, New Haven, CT, USA. · Department of Neurology, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA. · University of California-San Francisco and San Francisco Veteran's Affairs Medical Center, San Francisco, CA, USA. · Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. · Molecular Genetics Section, Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA. · Laboratory of Neuro Imaging, The Institute for Neuroimaging and Informatics, Keck School of Medicine of USC, University of Southern California, Los Angeles, CA, USA. · Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, 7.103 Founders Pavilion 3400 Spruce Street, Philadelphia, PA, 19104, USA. · Center for Neurodegenerative Disease Research, Institute on Aging, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. · Pubmed 27021906
  • Department of Neurology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA. · Department of Psychiatry, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA. · PD Research, Education and Clinical Center, Philadelphia Veterans Affairs Medical Center, Philadelphia, Pennsylvania, USA. · Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA. · Avid Radiopharmaceuticals, Philadelphia, Pennsylvania, USA. · Department of Biostatistics, University of Rochester School of Medicine, Rochester, New York, USA. · The Institute for Neurodegenerative Disorders, New Haven, Connecticut, USA. · Pubmed 26293177
2015
  • Department of Neurodegeneration, Hertie-Institute for Clinical Brain Research and German Center for Neurodegenerative Diseases, Tuebingen, Germany. · Department of Neurology, Montreal General Hospital, Montreal, Quebec, Canada. · The Parkinson's Disease and Movement Disorders Center, Department of Neurology, Mayo Clinic, Scottsdale, Arizona, USA. · Department of Neurology, Radboud University Medical Center, Donders Institute for Brain, Cognition and Behavior, Nijmegen, The Netherlands. · Xuanwu Hospital of Capitol of Medical University, Beijing, China. · Hopital De La Salpetriere, Paris, France. · Rush University Medical Center, Chicago, Illinois, USA. · Neuroscience Research Australia & University of NSW, Randwick, Australia. · Department of Epidemiology and Biostatistics, McGill University, Montreal, Quebec, Canada. · Division of Neurology, Toronto Western Hospital, Toronto, Ontario, Canada. · Department of Neurosciences, University of California San Diego, La Jolla, California, USA. · Institute for Neurodegenerative Disorders, New Haven, Connecticut, USA. · University of Navarra-FIMA, Pamplona, Spain. · Department of Neurology, Philipps University of Marburg, Marburg, Germany. · Department of Neurology, The Mount Sinai Hospital, New York, New York, USA. · Department of Neurology, Innsbruck Medical University, Innsbruck, Austria. · Penn Neurological Institute, Philadelphia, Pennsylvania, USA. · Department of Neurology, Christian-Albrechts University, Kiel, Germany. · Pubmed 26474317
  • Department of Neurology, Montreal General Hospital, Montreal, Quebec, Canada. · Department of Neurodegeneration, Hertie-Institute for Clinical Brain Research and German Center for Neurodegenerative Diseases, Tuebingen, Germany. · Penn Neurological Institute, Philadelphia, Pennsylvania, USA. · Department of Neurology, Innsbruck Medical University, Innsbruck, Austria. · Department of Neurology, The Mount Sinai Hospital, New York, New York, USA. · Department of Neurology, Philipps University of Marburg, Marburg, Germany. · University of Navarra-FIMA, Pamplona, Spain. · Institute for Neurodegenerative Disorders, New Haven, Connecticut, USA. · Department of Neurosciences, UC San Diego, La Jolla, California, USA. · Division of Neurology, Toronto Western Hospital, Toronto, Ontario, Canada. · Neuroscience Research Australia & University of NSW, Randwick, Australia. · Rush University Medical Center, Chicago, Illinois, USA. · Hopital De La Salpetriere, Paris, France. · Xuanwu Hospital of Capitol of Medical University, Beijing, Peoples Republic of China. · Department of Neurology, Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Nijmegen, Netherlands. · The Parkinson's Disease and Movement Disorders Center, Department of Neurology, Mayo Clinic, Scottsdale, Arizona, USA. · Department of Neurology, Christian-Albrechts University, Kiel, Germany. · Pubmed 26474316
  • Department of Medical and Molecular Genetics, Indiana University School of Medicine Indianapolis, Indiana, 46202. · Department of Neurology, Center for Human Genetic Research, Massachusetts General Hospital Boston, Massachusetts, 02114. · Michael J. Fox Foundation New York City, New York. · Institute for Neurodegenerative Disorders New Haven, Connecticut, 06510. · Pubmed 26436106
  • Critical Path Institute, CAMD, Tucson, AZ, USA. · Nuffield Department of Clinical Neurosciences, University of Oxford, Neurology Department, Level 3, West Wing, John Radcliffe Hospital, Headley Way, Headington, Oxford, UK. · Scientific consultant, London, UK. · Henry Wellcome Building, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK. · University of Bristol, Canynge Hall, Bristol, UK. · US Food and Drug Administration (FDA), New Hampshire Avenue, Silver Spring, MD, USA. · EMA, 30 Churchill Place, Canary Wharf, London, UK. · U of Rochester Medical Center, Crittenden Blvd, Rochester, NY, USA. · Michael J Fox Foundation for Parkinson's Research, Seventh Avenue, New York, NY, USA. · Aston University and MIT, Aston University, Aston Triangle, Birmingham, Media Lab, Massachusetts Institute of Technology, Cambridge, MA, USA. · Sage Bionetworks, Seattle, WA, USA. · Department of Psychiatry, University of Oxford, Warneford Hospital, Oxford, UK. · Department of Clinical Neuroscience, UCL Institute of Neurology, London, UK Department of Neurology, Royal Free Hospital, London, UK Neurology, National Hospital for Neurology, London, UK. · Institute of Neuroscience and Psychology, University of Glasgow, Scotland, UK. · National Institute of Neurological Disorders and Stroke (NINDS), Neuroscience Center, Bethesda, MD, USA. · Department of Psychiatry, University of Oxford Hospital, Warneford, Oxford, UK. · Department of Clinical Neurosciences, John Van Geest Centre for Brain Repair, University of Cambridge, E.D. Adrian Building, Forvie Site, Robinson Way, Cambridge, UK. · Independent Scientific & Medical Writer, Savits Drive, Elverson, PA, USA. · Institute of Neurodegenerative Diseases, Parkinson's Progression Markers Initiative, Suite 8B, New Haven, CT, USA. · Laboratory of Neuro Imaging, Keck School of Medicine of USC, University of Southern California, CA, USA. · Teva Pharmaceutical Industries Ltd., Petach Tikva, Israel. · Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA. · Parkinson's UK, London, UK. · Pubmed 26406139
  • Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA. · 23andMe, Mountain View, CA, USA. · Department of Neurology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. · Deptartment of Biostatistics and Computational Biology, University of Rochester Medical Center, Rochester, NY, USA. · The Michael J Fox Foundation for Parkinson's Research, New York, NY 10018, USA. · National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA. · INSERM, UMR 1043, Centre de Physiopathologie de Toulouse-Purpan, Toulouse, France; Paul Sabatier University, Toulouse, France. · Genome Biology of Neurodegenerative Diseases, German Center for Neurodegenerative Diseases, Tübingen, Germany. · Institute of Psychological Medicine and Clinical Neurosciences, MRCCentre for Neuropsychiatric Genetics and Genomics, Cardiff University, Cardiff, UK. · Reta Lila Weston Institute, University College London Institute of Neurology, London, UK. · Department for Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany. · Sorbonne Université, UPMC Univ Paris 06, UM 1127, ICM, Paris, France; INSERM, U 1127, and CNRS, UMR 7225, Institut du Cerveau et de la Moelle Epinière, Paris, France; AP-HP, Hôpital de la Salpêtrière, Département de Génétique et Cytogénétique, Paris, France. · Genetics and Pharmacogenomics, Merck Research Laboratories, West Point, PA, USA; Merck Research Laboratories, Boston, MA, USA. · Center for Neurodegenerative Disease Research, Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. · Department of Neurology, Georgetown University Medical Center, Washington, DC, USA. · Department of Neurology, University of Rochester Medical Center, Rochester, NY, USA. · Department of Neurology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA; Department of Psychiatry, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. · Department of Neurology, Division of Neurogenetics, VA Puget Sound Health Care System, Seattle, WA, USA. · Institute for Neurodegenerative Disorders, New Haven, CT, USA. · Precision Medicine, Biogen, Cambridge, MA, USA. · Meta-Research Innovation Center at Stanford (METRICS), Stanford University, Stanford, CA, USA; Department of Medicine, Stanford Prevention Research Center, Stanford, CA, USA; Department of Health Research and Policy, Stanford University School of Medicine, Stanford, CA, USA; Department of Statistics, Stanford University School of Humanities and Sciences, Stanford, CA, USA. · Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA. Electronic address: · Pubmed 26271532
  • Department of Veteran Affairs Medical Center, San Francisco, California, USA. · Department of Radiology and Biomedical Imaging, University of California, San Francisco, California, USA. · Department of Biostatistics, College of Public Health, University of Iowa, Iowa City, Iowa, USA. · Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA. · Institute for Neurodegenerative Disorders (IND) and Molecular Neuroimaging, LLC (MNI), New Haven, Connecticut, USA. · Baylor College of Medicine, Houston, Texas, USA. · Department of Neurology, University of California, San Francisco, CA, USA. · Emory University, Atlanta, Georgia, USA. · University of Tuebingen, Tuebingen, Germany. · Innsbruck Medical University, Innsbruck, Austria. · Paracelsus-Elena Klinik, Kassel, Germany. · Johns Hopkins University, Baltimore, Maryland, USA. · Macquarie University, Sydney, Australia. · Pubmed 26260437
  • Northwestern University Feinberg School of Medicine, Chicago, IL, USA. · The University of Iowa, Iowa City, IA, USA. · The University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA. · Institute for Neurodegenerative Disorders, New Haven, CT, USA. · Charitable Hertie Foundation, Frankfurt/Main, Germany. · Hephata-Klinik, Hephata Hessisches Diakoniezentrum e. V. · Innsbruck Medical University, Innsbruck, Austria. · McGill University, Montréal, Québec, Canada. · Massachusetts General Hospital, Boston, MA, USA. · UAB School of Medicine, Birmingham, AL, USA. · Pubmed 26095202
2014
  • Institute for Neurodegenerative Disorders, New Haven, CT, USA. · Department of Biostatistics and Computational Biology, University of Rochester, Rochester, NY, USA. · Program for Regulatory Science & Medicine (PRSM), Georgetown University, Washington, D.C., USA. · Pubmed 25062961
  • From the Institute for Neurodegenerative Disorders (D.J., J.S., K.M.), New Haven, CT · Parkinson's Disease and Movement Disorders Center (M.S.), Department of Neurology, University of Pennsylvania, Philadelphia · Department of Biostatistics and Computational Biology (S.E., D.O.), University of Rochester, NY · and Avid Radiopharmaceuticals (A.S.), Philadelphia, PA. · Pubmed 25298306
2013
  • 1 Critical Path Institute, Coalition Against Major Diseases, Tucson, AZ, USA. · 2 Independent science writer, Elverson, PA, USA. · 3 Alzheimer's Association, Chicago, IL, USA. · 4 Pfizer Inc, New London, CT, USA. · 5 Arizona State University, Phoenix, AZ, USA. · 6 Boehringer Ingelheim Pharmaceuticals Inc, Ridgefield, CT, USA. · 7 Mayo Clinic, Rochester, MN, USA. · 8 Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA. · 9 Eisai Inc, Woodcliff Lake, NJ, USA. · 10 Institute for Neurodegenerative Disorders, New Haven, CT, USA. · 11 Metrum Research Group, Tariffville, CT, USA. · Current affiliation: Synergia Consulting, MI, USA. · 12 Johnson & Johnson, Raritan, NJ, USA. · 13 Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. · 14 US Food and Drug Administration, Silver Spring, MD, USA. · 15 USAgainst Alzheimer's, Washington, DC, USA. · 16 European Medicines Agency (EMA), London, UK. · Pubmed 30235546
2012
  • Institute for Neurodegenerative Disorders, New Haven, CT, USA. · Pubmed 23026362
Probable:    Miscellaneous cities in USA      
2019
  • Northwestern University Feinberg School of Medicine, USA. Electronic address: · The University of Iowa, USA. Electronic address: · The University of Iowa, USA. Electronic address: · The University of Pennsylvania, USA. Electronic address: · University of California San Francisco, USA. Electronic address: · University of Rochester Medical Center, USA. Electronic address: · Center of Parkinsonism and Movement Disorders Paracelsus-Elena Klinik Kassel and University Medical Center Goettingen, Germany. Electronic address: · University of California San Diego, USA. Electronic address: · TransThera Consulting, USA. Electronic address: · Indiana University, USA. Electronic address: · University of Pittsburgh, USA. Electronic address: · The University of Pennsylvania, USA. Electronic address: · University of Rochester Medical Center, USA. Electronic address: · University of Rochester Medical Center, USA. Electronic address: · Clinical Trial Coordination Center, University of Rochester Medical Center, USA. Electronic address: · Michael J Fox Foundation, USA. · Institute for Neurodegenerative Disorders, USA. Electronic address: · Michael J Fox Foundation, USA. Electronic address: · Michael J Fox Foundation, USA. Electronic address: · Michael J Fox Foundation, USA. Electronic address: · Institute for Neurodegenerative Disorders, USA. Electronic address: · Harvard Medical School, Beth Israel Deaconess Medical Center, Parkinson's Disease and Movement Disorders Center, Director of the HDSA Center of Excellence, USA. Electronic address: · Denali Therapeutics, USA. Electronic address: · Northwestern University Feinberg School of Medicine, USA. Electronic address: · Pubmed 30738748
Probable:    Yale University   Contact    
2017
  • Department of Physiology, Emory University, 615 Michael Street, 605L Whitehead Biomedical Res. Bldg., Atlanta, GA, 30322, USA. · Department of Biostatistics, University of Iowa, 145 N. Riverside Drive, 100 CPHB, Iowa City, Iowa, 52242, USA. · BioLegend, Inc., 180 Rustcraft Rd # 140, Dedham, Massachusetts, 02026, USA. · Paracelsus-Elena-Klinik, 34128 Kassel, Kassel, Germany. · Georg-August University Medical Center Goettingen, 37075, Goettingen, Germany. · Program in Neuroscience and Division of Neurology, The Ottawa Hospital, University of Ottawa Brain & Mind Institute, 451 Smyth Road, Room 1412, Ottawa, K1H 8M5, Canada. · Follow the Molecule, 143 Voyage Mall, Marina del Rey, CA, 90292, USA. · PAREXEL International, Early Phase Unit, 1560 E. Chevy Chase Drive, Suite 140, Glendale, CA, 91206, USA. · Research Programs, The Michael J. Fox Foundation for Parkinson's Research, 69 7th Avenue, 498, New York, NY, 10018, USA. · Yale-New Haven Hospital, 20 York Street, New Haven, CT, 06510, USA. · Nell Hodgson Woodruff School of Nursing, Emory University, 1520 Clifton Rd, Atlanta, GA, 30322, USA. · Department of Physiology, Emory University, 615 Michael Street, 605L Whitehead Biomedical Res. Bldg., Atlanta, GA, 30322, USA. · Pubmed 28821274
2012
  • Yale University School of Medicine, New Haven, Connecticut 06519, USA. · Pubmed 22609082
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 60 total) written by Kenneth Marek about Parkinson Disease:

  • Comparison of an Online-Only Parkinson's Disease Research Cohort to Cohorts Assessed In Person. 2020
  • Predicting Progression in Parkinson's Disease Using Baseline and 1-Year Change Measures. 2019
  • Longitudinal analyses of cerebrospinal fluid α-Synuclein in prodromal and early Parkinson's disease. 2019
  • Feasibility and safety of lumbar puncture in the Parkinson's disease research participants: Parkinson's Progression Marker Initiative (PPMI). 2019
  • Finding useful biomarkers for Parkinson's disease. 2018
  • 123I-FP-CIT SPECT [(123) I-2β-carbomethoxy-3β-(4-iodophenyl)-N-(3-fluoropropyl) nortropane single photon emission computed tomography] Imaging in a p.A53T α-synuclein Parkinson's disease cohort versus Parkinson's disease. 2018
  • Movement disorder society criteria for clinically established early Parkinson's disease. 2018
  • Plasma α-synuclein and cognitive impairment in the Parkinson's Associated Risk Syndrome: A pilot study. 2018
  • Longitudinal Change of Clinical and Biological Measures in Early Parkinson's Disease: Parkinson's Progression Markers Initiative Cohort. 2018
  • Baseline prevalence and longitudinal evolution of non-motor symptoms in early Parkinson's disease: the PPMI cohort. 2018
Show List of Full Article Records
Google Searches

Learn more about Kenneth Marek using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Miscellaneous institutions in New Haven
Miscellaneous cities in USA
Yale University
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Miscellaneous institutions in New Haven
2020
  • University of Pittsburgh, Pittsburgh, PA, USA. · Blackfynn, Philadelphia, PA, USA. · University of Iowa, Iowa City, IA, USA. · University of Alabama at Birmingham, Birmingham, AL, USA. · University of California, and San Francisco Veterans Affairs Medical Care Plan, San Francisco, CA, USA. · The Michael J. Fox Foundation for Parkinson's Research, New York, NY, USA. · Rutgers, The State University of New Jersey, Piscataway, NJ, USA. · University of Rochester, Rochester, NY, USA. · Theravance Biopharma, San Francisco, CA, USA. · 23and Me Inc., Mountain View, CA, USA. · Institute for Neurodegenerative Disorders, New Haven, CT, USA. · Toronto Western Hospital, Toronto, Canada. · Pubmed 31958097
2019
  • Department of Neurology, University of Pittsburgh, Pittsburgh, PA, USA. · Departments of Neurology Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. · Department of Biostatistics, College of Public Health, University of Iowa, Iowa City, IA, USA. · Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA. · Department of Neurology, University of California, San Diego, CA, USA. · Department of Neurology, University Medical Center Goettingen, Goettingen, Germany and Paracelsus-Elena-Klinik, Kassel, Germany. · The Michael J. Fox Foundation, New York, NY, USA. · Institute for Neurodegenerative Disorders, New Haven, CT, USA. · Department of Neurology, University of California San Francisco, San Francisco, CA, USA. · Department of Neurology, University of Rochester Medical Center, Rochester, NY, USA. · Pubmed 31450510
  • Department of Neurology, University Medical Center Goettingen, Göttingen, Germany; and Paracelsus-Elena Klinik, Kassel, Germany. · Department of Biostatistics, College of Public Health, University of Iowa, Iowa City, Iowa, USA. · BioLegend Inc., San Diego, California, USA. · Molecular Genetics Section, Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, Maryland, USA. · Department of Pathology & Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA. · Center for Neurodegenerative Disease Research, Institute on Aging, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA. · Morris K. Udall Center of Excellence for Parkinson's Disease Research, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA. · The Michael J. Fox Foundation for Parkinson's Research, New York, New York, USA. · Parkinson's Disease and Movement Disorders Center, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA. · Neurological Service, Hospital Clinic de Barcelona, Barcelona, Spain. · Department of Neurology, Philipps University Marburg, Marburg, Germany. · Department of Neurology Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA. · Institute for Neurodegenerative Disorders, New Haven, Connecticut, USA. · University of Southern California, Laboratory of Neuro Imaging, Los Angeles, California, USA. · Department of Neurology, University of California San Francisco, San Francisco, California, USA. · Clinical Trials Coordination Center, University of Rochester Medical Center, Rochester, New York, USA. · Department of Neurology, University of Pittsburgh, Pittsburgh, Pennsylvania, USA. · Department of Neurosciences, University of California, San Diego, San Diego, California, USA. · Pubmed 31361367
2018
  • Department of Neurology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA 19104, USA. · Neurology Service and GRECC, VAAHS, Ann Arbor, MI 48105, USA. · Department of Neurology, University of Michigan, Ann Arbor, MI 48109, USA. · Department of Neurology, Columbia University Medical Center, New York, NY 10032, USA. · National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD 20824, USA. · Verily/Google Life Sciences, South San Francisco, CA 94080, USA. · Department of Biostatistics, Mailman School of Public Health, Columbia University, New York, NY 10032, USA. · Human Metabolome Technology-America, Boston, MA 02134, USA. · Biogen, Cambridge, MA 02142, USA. · Caprion Biosciences, Montreal, Quebec H2X 3Y7, Canada. · Cell Biology and Gene Expression Section, Laboratory of Neurogenetics, National Institute of Aging, National Institutes of Health, Bethesda, MD 20892, USA. · Institute for Cell Engineering, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA. · Department of Neurology and Neurotherapeutics, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA. · Department of Medical and Molecular Genetics, Indiana University School of Medicine, Indianapolis, IN 46202, USA. · The Michael J. Fox Foundation for Parkinson's Research, New York, NY 10163, USA. · Department of Psychiatry, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA. · Department of Neurology, Penn State University-Hershey Medical Center, Hershey, PA 17033, USA. · Pharmaceutical Research and Early Development, NORD Discovery and Translational Area, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., 4070 Basel, Switzerland. · Institute for Neurodegenerative Disorders, New Haven, CT 06510, USA. · Departments of Cancer Biology and Pathology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA. · Blais Proteomics Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02215, USA. · Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02215, USA. · Chaperone Therapeutics, Portland, OR 97229, USA. · Paracelsus-Elena-Klinik, 34128 Kassel, Germany. · University Medical Center, 37075 Goettingen, Germany. · Department of Cellular and Molecular Pharmacology, Chicago Medical School, Rosalind Franklin University of Medicine and Science, Chicago, IL 60064, USA. · Department of Neurology, Johns Hopkins School of Medicine, Baltimore, MD 21205, USA. · Department of Neurology, Mount Sinai Beth Israel, Icahn School of Medicine at Mount Sinai, New York, NY 10003, USA. · Center for Advanced Parkinson's Disease Research and Precision Neurology Program, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. · Laboratory of Neurogenetics, National Institute on Aging, Bethesda, MD 20892, USA. · Luxembourg Centre for Systems Biomedicine, University of Luxembourg, Luxembourg, Luxembourg. · Genentech, San Francisco, CA 94080, USA. · Neurogenomics Division, Translational Genomics Research Institute, Phoenix, AZ 85004, USA. · Department of Applied Physiology, Biomedical Engineering, and Neurology, University of Florida, Gainesville, FL 32611, USA. · Department of Neurology, University of Alabama, Birmingham, AL 35233, USA. · Department of Pathology, University of Washington, Seattle, WA 98195, USA. · Pubmed 30111645
  • 1st Neurology Clinic, Eginition Hospital, Athens University Medical School, Athens, Greece. · 2nd Neurology Clinic, Attikon Hospital, Athens University Medical School, Athens, Greece. · Nuclear Medicine Unit, Attikon Hospital, Athens, Greece. · Neurology Clinic, Henry Dunan Hospital, Athens, Greece. · Institute for Neurodegenerative Disorders, New Haven, Connecticut, USA. · Neurology Clinic, Philipps University, Marburg, Germany. · Parkinson's Disease and Movement Disorders Department, HYGEIA Hospital, Athens, Greece. · Pubmed 30288781
  • Department of Neurology, Christian-Albrechts-University of Kiel, Kiel, Germany. · Department of Neurodegeneration, Hertie-Institute for Clinical Brain Research, Tübingen, Germany. · The Parkinson's Disease and Movement Disorders Center, Department of Neurology, Mayo Clinic, Scottsdale, Arizona, USA. · Department of Neurology, Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Nijmegen, Netherlands. · Xuanwu Hospital of Capitol of Medical University, Beijing, Peoples Republic of China. · Rush University Medical Center, Chicago, Illinois, USA. · Neuroscience Research Australia & University of New South Wales, Randwick, Australia. · Edmond J. Safra Program in Parkinson's Disease and the Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital, Toronto, Ontario, Canada. · Brain and Mind Centre University of Sydney, Camperdown, Australia. · German Center for Neurodegenerative Diseases, Tübingen, Germany. · Department of Neurosciences, University of California San Diego, La Jolla, California, USA. · Institute for Neurodegenerative Disorders, New Haven, Connecticut, USA. · University of Navarra-Fundación para la Investigación Médica Aplicada (FIMA), Pamplona, Spain. · Department of Neurology, Philipps University of Marburg, Marburg, Germany. · Department of Neurology, Mount Sinai School of Medicine, New York, New York, USA. · Department of Neurology, Innsbruck Medical University, Innsbruck, Austria. · Department of Neurology, Montreal General Hospital, Montreal, Quebec, Canada. · Penn Neurological Institute, Philadelphia, Pennsylvania, USA. · University of California, San Francisco, California, USA. · Pubmed 30145841
  • Department of Pathology, Peking University Health Science Centre and Third Hospital, Beijing 100191, China; Department of Pathology, University of Washington School of Medicine, Seattle, WA 98104-2499, USA. · Department of Pathology, University of Washington School of Medicine, Seattle, WA 98104-2499, USA. · Department of Biostatistics, University of Washington, Seattle, Washington, USA. · The institute for Neurodegenerative Disorders, New Haven, CT, USA. · University of Aarhus, DANDRITE-Danish Research Institute of Translational Neuroscience & Department of Biomedicine, Aarhus, Denmark. · Department of Pathology, Peking University Health Science Centre and Third Hospital, Beijing 100191, China; Department of Pathology, University of Washington School of Medicine, Seattle, WA 98104-2499, USA. Electronic address: · Pubmed 29705185
  • Northwestern University, Chicago, Illinois, USA. · University of Pennsylvania, Philadelphia, Pennsylvania, USA. · Institute for Neurodegenerative Disorders, New Haven, Connecticut, USA. · University of Iowa, Iowa City, Iowa, USA. · Eli Lilly, Indianapolis, Indiana, USA. · University of California, San Francisco, California, USA. · National Institute on Aging, National Institutes of Health, Bethesda, Maryland, USA. · Clinical Trials Coordination Center, University of Rochester, Rochester, New York, USA. · University of Southern California, Los Angeles, California, USA. · Paracelsus-Elena Klinik, Kassel, Germany. · University of California, San Diego, California, USA. · Indiana University, Indianapolis, Indiana, USA. · Stanford University Medical Center, Stanford, California, USA. · Michael J Fox Foundation, New York, NY, USA. · Pubmed 29572948
  • Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA. · Department of Biostatistics, University of Iowa, Iowa City, Iowa, USA. · University of Pennsylvania School of Medicine and the Parkinson's Disease and Mental Illness Research, Education and Clinical Centers (PADRECC and MIRECC), Philadelphia Veterans Affairs Medical Center, Philadelphia, Pennsylvania, USA. · Center of Parkinsonism and Movement Disorders Paracelsus-Elena Klinik Kassel, University Medical Center Goettingen, Kassel, Germany. · Institute for Neurodegenerative Disorders, New Haven, Connecticut, USA. · University of California San Francisco, San Francisco, California, USA. · Eli Lilly and Company, Indianapolis, Indiana, USA. · University of Rochester Medical Center, Rochester, New York, USA. · University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania, USA. · Pubmed 28986467
  • Critical Path Institute, Tucson, Arizona, USA. · Pfizer Inc, Groton, Connecticut, USA. · Merck Sharp & Dohme, North Wales, Pennsylvania, USA. · UCB, Brussels, Belgium. · Eli Lilly, Indianapolis, Indiana, USA. · University of Arizona, Tucson, Arizona, USA. · Institute for Neurodegenerative Disorders, New Haven, Connecticut, USA. · Pubmed 28749580
2017
  • a Parkinson's Disease and Movement Disorders Center of Boca Raton , FL , USA. · b Saint Luke's Marion Bloch Neuroscience Institute , Kansas City , MO , USA. · c Hackensack University Medical Center, Movement Disorders Center , Hackensack , NJ , USA. · d Irvine Health Movement Disorders Program , University of California , Irvine , CA , USA. · e Thomas Jefferson University, Sidney Kimmel Medical College , Philadelphia , PA , USA. · f University of Southern California Keck School of Medicine , Los Angeles , CA , USA. · g Institute for Neurodegenerative Disorders , New Haven , CT , USA. · h University of Kansas Medical Center , Kansas City , KS , USA. · Pubmed 27813429
  • Institute for Neurodegenerative Disorders, New Haven, Connecticut. · Avid Radiopharmaceuticals, Philadelphia, Pennsylvania. · Pubmed 29114721
  • Department of Neurology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA. · Department of Psychiatry, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA. · PD Research, Education and Clinical Center, Philadelphia Veterans Affairs Medical Center, Philadelphia, Pennsylvania, USA. · Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA. · Department of Biostatistics and Computational Biology, University of Rochester Medical Center, Rochester, New York, USA. · The Institute for Neurodegenerative Disorders, New Haven, Connecticut, USA. · Eli Lilly and Company, Indianapolis, Indiana, USA. · Pubmed 29063713
  • From the Department of Neurology (B.M.), University Medical Center, Göttingen · Paracelsus-Elena-Klinik (B.M.), Kassel, Germany · Department of Biostatistics (C.J.C.-G., C.S.C.), College of Public Health, University of Iowa, Iowa City · BioLegend Inc. (P.T.), San Diego, CA · Department of Pathology & Laboratory Medicine (L.M.S., J.Q.T.), Center for Neurodegenerative Disease Research, Institute on Aging (L.M.S. , J.Q.T.), and Morris K. Udall Center of Excellence for Parkinson's Disease Research (J.Q.T.), Perelman School of Medicine, University of Pennsylvania, Philadelphia · Molecular Genetics Section (A.S.), Laboratory of Neurogenetics, National Institute on Aging, NIH, Bethesda, MD · The Michael J. Fox Foundation for Parkinson's Research (M.F.), New York, NY · Institute for Neurodegenerative Disorders (K.M.), New Haven, CT · and Department of Neurosciences (D.G.), University of California, San Diego. · Pubmed 29030452
  • Parkinson's Disease Research, Education, and Clinical Center (PADRECC), Philadelphia VA Medical Center, Philadelphia, Pennsylvania, USA. · Department of Neurology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA. · Department of Biostatistics and Epidemiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA. · Institute for Neurodegenerative Disorders, New Haven, Connecticut, USA. · Parkinson's Associated Risk Study, New Haven, Connecticut, USA. · Eli Lilly and Company, New York, New York, USA. · Pubmed 28906025
  • GNS Healthcare, Cambridge, Massachusetts, United States of America. · Novartis, Cambridge, Massachusetts, United States of America. · Alexion Pharmaceuticals, Cambridge, Massachusetts, United States of America. · University of Rochester, Rochester, New York, United States of America. · Morton and Gloria Movement Disorders Clinic and the Edmond J. Safra Program in Parkinson's Disease, Toronto Western Hospital and the University of Toronto, Toronto, Ontario, Canada. · Institute for Neurodegenerative Disorders, New Haven, Connecticut, United States of America. · Georgetown University, Washington, DC, United States of America. · National Institute on Aging, NIH, Bethesda, Maryland, United States of America. · University of San Francisco & San Francisco Veterans Affairs Medical Center, San Francisco, California, United States of America. · Biogen Idec, Cambridge, Massachusetts, United States of America. · Voyager Therapeutics, Cambridge, Massachusetts, United States of America. · Pubmed 28604798
  • Institute for Neurodegenerative Disorders, New Haven, Connecticut. · Avid Radiopharmaceuticals, Philadelphia, Pennsylvania. · Parkinson's Disease and Movement Disorders Center, Department of Neurology, University of Pennsylvania, Philadelphia. · Department of Biostatistics and Computational Biology, University of Rochester, Rochester, New York. · Pubmed 28595287
  • Department of Neurology, The University of Alabama at Birmingham, Birmingham, Alabama, USA. · Department of Neurology, The University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA. · Department of Biostatistics, The University of Iowa, Iowa City, Iowa, USA. · Department of Neurology, Innsbruck Medical University, Innsbruck, Austria. · Department of Neurology, Massachusetts General Hospital, Boston, Massachusetts, USA. · Neurology Service, Hospital Clinic de Barcelona, IDIBAPS, CIBERNED, Barcelona, Spain. · Department of Neurology, Hephata-Klinik, Hephata Hessisches Diakoniezentrum, e.V., Schwalmstadt-Treysa, Germany. · Cleveland Clinic Neurological Institute, Cleveland, Ohio, USA. · Division of Neurology, McGill University, Montreal, Québec, Canada. · Department of Neurology, Philipps University, Marburg, Germany. · Charitable Hertie Foundation, Frankfurt, Germany. · Institute for Neurodegenerative Disorders, New Haven, Connecticut, USA. · Department of Neurology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA. · Pubmed 28554959
  • Parkinson's Disease and Movement Disorders Unit, Neurology Service, Hospital Clinic de Barcelona, Universitat de Barcelona, Institut d'Investigacions Biomediques August Pi I Sunyer (IDIBAPS), Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Barcelona, Spain. · Neurology Unit, Hospital General de Granollers, Universitat Internacional de Catalunya, Granollers, Spain. · Department of Biostatistics, College of Public Health, University of Iowa, Iowa City, Iowa, USA. · Department of Neurology, College of Physicians and Surgeons, Columbia University, New York, New York, USA. · Departments of Neurology and Neurobiology, Xuanwu Hospital of Capital Medical University, Beijing, China. · Parkinson's Disease Research, Education and Clinical Center, Michael J. Crescenz VA Medical Center and Department of Neurology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA. · The Michael J. Fox Foundation for Parkinson's Research, New York, New York, USA. · Laboratory of Neurodegenerative Disorders, Department of Neurology, Hospital Clínic of Barcelona, Institutd'InvestigacionsBiomèdiques August Pi i Sunyer (IDIBAPS), University of Barcelona, and the Centre for Networked Biomedical Research on Neurodegenerative Diseases (CIBERNED), Madrid, Spain. · Institute for Neurodegenerative Disorders and Molecular NeuroImaging, New Haven, Connecticut, USA. · Department of Nuclear Medicine, Hospital Clinic de Barcelona, Universitat de Barcelona, Institut d'Investigacions Biomediques August Pi I Sunyer (IDIBAPS), Barcelona, Spain. · Toronto Western Hospital Morton and Gloria Shulman Movement Disorders Centre and the Edmond J. Safra Program in Parkinson's Disease, University of Toronto, Toronto, Ontario, Canada. · Department of Neurology, Movement Disorders Unit. Hospital Universitario Donostia. Biodonostia Research Institute, Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), San Sebastián, Guipúzcoa, Spain. · Department of Neurology, Mount Sinai Beth Israel Medical Center and Icahn School of Medicine at Mount Sinai, New York, New York, USA. · Department of Neurology, Norwegian University of Science and Technology, Trondheim, Norway. · Pubmed 28370517
2016
  • Atlantic Neuroscience Institute Summit New Jersey USA. · Voyager Therapeutics Cambridge Massachusetts USA. · Department of Biostatistics and Computational Biology University of Rochester Rochester New York USA. · Toronto Western Hospital Toronto Ontario Canada. · The Parkinson's Institute Sunnyvale California USA. · Institute for Neurodegenerative Disorders New Haven Connecticut USA. · Columbia University New York New York USA. · Parkinson's Disease Foundation New York New York USA. · Georgetown University Washington District of Columbia USA. · Pubmed 30363507
  • Department of Neurology, Montreal General Hospital, Montreal, Quebec, Canada. · Department of Neurodegeneration, Hertie-Institute for Clinical Brain Research and German Center for Neurodegenerative Diseases, Tuebingen, Germany. · Penn Neurological Institute, Philadelphia, Pennsylvania, USA. · Department of Neurology, Innsbruck Medical University, Innsbruck, Austria. · Department of Neurology, The Mount Sinai Hospital, New York, New York, USA. · Department of Neurology, Philipps University of Marburg, Marburg, Germany. · Institute for Neurodegenerative Disorders, New Haven, Connecticut, USA. · Department of Neurosciences, UC San Diego, La Jolla, California, USA. · Division of Neurology, Toronto Western Hospital, Toronto, Ontario, Canada. · Neuroscience Research Australia & University of NSW, Randwick, Australia. · Rush University Medical Center, Chicago, Illinois, USA. · Hopital De La Salpetriere, Paris, France. · Xuanwu Hospital of Capitol of Medical University, Beijing, People's Republic of China. · Department of Neurology, Radboud university medical center, Donders Institute for Brain, Cognition and Behaviour, Nijmegen, Netherlands. · The Parkinson's Disease and Movement Disorders Center, Department of Neurology, Mayo Clinic, Scottsdale, Arizona, USA. · Department of Neurology, Christian-Albrechts University, Kiel, Germany. · Pubmed 27666574
  • Neurology Parkinson's Disease and Movement Disorders Center Northwestern University Chicago Illinois. · University of Iowa iowa City Iowa. · Clinical Trials Statistical & Data Management Center University of Iowa College of Public Health iowa City iowa. · Institute for Neurodegenerative Disorders (IND) Molecular NeuroImaging LLC (MNI) New Haven Connecticut. · Neurology University of California San Francisco California. · Center for Human Experimental Therapeutics University of Rochester Rochester New York. · Pubmed 27386498
  • Department of Neurology Perelman School of Medicine at the University of Pennsylvania Philadelphia Pennsylvania. · Department of Biostatistics and Epidemiology Perelman School of Medicine at the University of Pennsylvania Philadelphia Pennsylvania. · Department of Psychiatry Perelman School of Medicine at the University of Pennsylvania Philadelphia Pennsylvania. · Parkinson's Associated Risk Study New Haven, CT USA; Institute for Neurodegenerative Disorders New Haven Connecticut. · Department of Neurology Perelman School of Medicine at the University of Pennsylvania Philadelphia Pennsylvania; Parkinson's Associated Risk Study New Haven, CT USA. · Avid Radiopharmaceuticals Philadelphia Pennsylvania. · Department of Pathology and Laboratory Medicine Perelman School of Medicine at the University of Pennsylvania Philadelphia Pennsylvania. · Pubmed 27231704
  • Parkinson's Disease and Movement Disorders Unit, Neurology Service, Institut de Neurociències Hospital Clínic, University of Barcelona, Catalonia, Spain. · Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania, USA. · BioLegend Inc, Dedham, Massachusetts, USA. · Department of Neurodegenerative Diseases and Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany. · Department of Neuroscience, Norwegian University of Science and Technology, Trondheim, Norway. · Department of Neurology, St. Olav's Hospital, Trondheim, Norway. · Morton and Gloria Shulman Movement Disorders Centre and the Edmond J Safra Program in Parkinson's Disease, Toronto Western Hospital, Toronto, Ontario, Canada. · Biostatistics and Data Management Core Facility, IDIBAPS (Hospital Clinic), Barcelona, Spain. · Biostatistics Unit, Faculty of Medicine, Universitat Autònoma de Barcelona, Catalonia, Spain. · Institute for Neurodegenerative Disorders, New Haven, Connecticut, USA. · Centro en Red para la Investigación de Enfermedades Neurodegenerativas CIBERNED, Spain. · Pubmed 27041685
  • Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, 7.103 Founders Pavilion 3400 Spruce Street, Philadelphia, PA, 19104, USA. · Department of Pharmacology, Hypoxia-related Disease Research Center, Inha University School of Medicine, Incheon, Republic of Korea. · Paracelsus-Elena Klinik, Kassel, Germany. · Department of Neuropathology and Neurosurgery, University Medical Center Goettingen, Göttingen, Germany. · Department of Biostatistics, College of Public Health, University of Iowa, Iowa City, IA, USA. · Center for Neurodegenerative Disease Research, Institute on Aging, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. · Department of Neurology, Morris K. Udall Center of Excellence for Parkinson's Disease Research, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. · Department of Psychiatry, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. · Department of Veterans Affairs, Philadelphia, PA, USA. · Department of Neurosciences, University of California, San Diego, CA, USA. · BioLegend Inc., Dedham, MA, USA. · The Michael J. Fox Foundation for Parkinson's Research, New York, NY, USA. · Institute for Neurodegenerative Disorders, New Haven, CT, USA. · Department of Neurology, University of Rochester School of Medicine and Dentistry, Rochester, NY, USA. · University of California-San Francisco and San Francisco Veteran's Affairs Medical Center, San Francisco, CA, USA. · Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA. · Molecular Genetics Section, Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA. · Laboratory of Neuro Imaging, The Institute for Neuroimaging and Informatics, Keck School of Medicine of USC, University of Southern California, Los Angeles, CA, USA. · Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, 7.103 Founders Pavilion 3400 Spruce Street, Philadelphia, PA, 19104, USA. · Center for Neurodegenerative Disease Research, Institute on Aging, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. · Pubmed 27021906
  • Department of Neurology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA. · Department of Psychiatry, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania, USA. · PD Research, Education and Clinical Center, Philadelphia Veterans Affairs Medical Center, Philadelphia, Pennsylvania, USA. · Department of Psychiatry, Yale University School of Medicine, New Haven, Connecticut, USA. · Avid Radiopharmaceuticals, Philadelphia, Pennsylvania, USA. · Department of Biostatistics, University of Rochester School of Medicine, Rochester, New York, USA. · The Institute for Neurodegenerative Disorders, New Haven, Connecticut, USA. · Pubmed 26293177
2015
  • Department of Neurodegeneration, Hertie-Institute for Clinical Brain Research and German Center for Neurodegenerative Diseases, Tuebingen, Germany. · Department of Neurology, Montreal General Hospital, Montreal, Quebec, Canada. · The Parkinson's Disease and Movement Disorders Center, Department of Neurology, Mayo Clinic, Scottsdale, Arizona, USA. · Department of Neurology, Radboud University Medical Center, Donders Institute for Brain, Cognition and Behavior, Nijmegen, The Netherlands. · Xuanwu Hospital of Capitol of Medical University, Beijing, China. · Hopital De La Salpetriere, Paris, France. · Rush University Medical Center, Chicago, Illinois, USA. · Neuroscience Research Australia & University of NSW, Randwick, Australia. · Department of Epidemiology and Biostatistics, McGill University, Montreal, Quebec, Canada. · Division of Neurology, Toronto Western Hospital, Toronto, Ontario, Canada. · Department of Neurosciences, University of California San Diego, La Jolla, California, USA. · Institute for Neurodegenerative Disorders, New Haven, Connecticut, USA. · University of Navarra-FIMA, Pamplona, Spain. · Department of Neurology, Philipps University of Marburg, Marburg, Germany. · Department of Neurology, The Mount Sinai Hospital, New York, New York, USA. · Department of Neurology, Innsbruck Medical University, Innsbruck, Austria. · Penn Neurological Institute, Philadelphia, Pennsylvania, USA. · Department of Neurology, Christian-Albrechts University, Kiel, Germany. · Pubmed 26474317
  • Department of Neurology, Montreal General Hospital, Montreal, Quebec, Canada. · Department of Neurodegeneration, Hertie-Institute for Clinical Brain Research and German Center for Neurodegenerative Diseases, Tuebingen, Germany. · Penn Neurological Institute, Philadelphia, Pennsylvania, USA. · Department of Neurology, Innsbruck Medical University, Innsbruck, Austria. · Department of Neurology, The Mount Sinai Hospital, New York, New York, USA. · Department of Neurology, Philipps University of Marburg, Marburg, Germany. · University of Navarra-FIMA, Pamplona, Spain. · Institute for Neurodegenerative Disorders, New Haven, Connecticut, USA. · Department of Neurosciences, UC San Diego, La Jolla, California, USA. · Division of Neurology, Toronto Western Hospital, Toronto, Ontario, Canada. · Neuroscience Research Australia & University of NSW, Randwick, Australia. · Rush University Medical Center, Chicago, Illinois, USA. · Hopital De La Salpetriere, Paris, France. · Xuanwu Hospital of Capitol of Medical University, Beijing, Peoples Republic of China. · Department of Neurology, Radboud University Medical Center, Donders Institute for Brain, Cognition and Behaviour, Nijmegen, Netherlands. · The Parkinson's Disease and Movement Disorders Center, Department of Neurology, Mayo Clinic, Scottsdale, Arizona, USA. · Department of Neurology, Christian-Albrechts University, Kiel, Germany. · Pubmed 26474316
  • Department of Medical and Molecular Genetics, Indiana University School of Medicine Indianapolis, Indiana, 46202. · Department of Neurology, Center for Human Genetic Research, Massachusetts General Hospital Boston, Massachusetts, 02114. · Michael J. Fox Foundation New York City, New York. · Institute for Neurodegenerative Disorders New Haven, Connecticut, 06510. · Pubmed 26436106
  • Critical Path Institute, CAMD, Tucson, AZ, USA. · Nuffield Department of Clinical Neurosciences, University of Oxford, Neurology Department, Level 3, West Wing, John Radcliffe Hospital, Headley Way, Headington, Oxford, UK. · Scientific consultant, London, UK. · Henry Wellcome Building, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK. · University of Bristol, Canynge Hall, Bristol, UK. · US Food and Drug Administration (FDA), New Hampshire Avenue, Silver Spring, MD, USA. · EMA, 30 Churchill Place, Canary Wharf, London, UK. · U of Rochester Medical Center, Crittenden Blvd, Rochester, NY, USA. · Michael J Fox Foundation for Parkinson's Research, Seventh Avenue, New York, NY, USA. · Aston University and MIT, Aston University, Aston Triangle, Birmingham, Media Lab, Massachusetts Institute of Technology, Cambridge, MA, USA. · Sage Bionetworks, Seattle, WA, USA. · Department of Psychiatry, University of Oxford, Warneford Hospital, Oxford, UK. · Department of Clinical Neuroscience, UCL Institute of Neurology, London, UK Department of Neurology, Royal Free Hospital, London, UK Neurology, National Hospital for Neurology, London, UK. · Institute of Neuroscience and Psychology, University of Glasgow, Scotland, UK. · National Institute of Neurological Disorders and Stroke (NINDS), Neuroscience Center, Bethesda, MD, USA. · Department of Psychiatry, University of Oxford Hospital, Warneford, Oxford, UK. · Department of Clinical Neurosciences, John Van Geest Centre for Brain Repair, University of Cambridge, E.D. Adrian Building, Forvie Site, Robinson Way, Cambridge, UK. · Independent Scientific & Medical Writer, Savits Drive, Elverson, PA, USA. · Institute of Neurodegenerative Diseases, Parkinson's Progression Markers Initiative, Suite 8B, New Haven, CT, USA. · Laboratory of Neuro Imaging, Keck School of Medicine of USC, University of Southern California, CA, USA. · Teva Pharmaceutical Industries Ltd., Petach Tikva, Israel. · Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA. · Parkinson's UK, London, UK. · Pubmed 26406139
  • Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA. · 23andMe, Mountain View, CA, USA. · Department of Neurology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. · Deptartment of Biostatistics and Computational Biology, University of Rochester Medical Center, Rochester, NY, USA. · The Michael J Fox Foundation for Parkinson's Research, New York, NY 10018, USA. · National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA. · INSERM, UMR 1043, Centre de Physiopathologie de Toulouse-Purpan, Toulouse, France; Paul Sabatier University, Toulouse, France. · Genome Biology of Neurodegenerative Diseases, German Center for Neurodegenerative Diseases, Tübingen, Germany. · Institute of Psychological Medicine and Clinical Neurosciences, MRCCentre for Neuropsychiatric Genetics and Genomics, Cardiff University, Cardiff, UK. · Reta Lila Weston Institute, University College London Institute of Neurology, London, UK. · Department for Neurodegenerative Diseases, Hertie Institute for Clinical Brain Research, University of Tübingen, Tübingen, Germany. · Sorbonne Université, UPMC Univ Paris 06, UM 1127, ICM, Paris, France; INSERM, U 1127, and CNRS, UMR 7225, Institut du Cerveau et de la Moelle Epinière, Paris, France; AP-HP, Hôpital de la Salpêtrière, Département de Génétique et Cytogénétique, Paris, France. · Genetics and Pharmacogenomics, Merck Research Laboratories, West Point, PA, USA; Merck Research Laboratories, Boston, MA, USA. · Center for Neurodegenerative Disease Research, Department of Pathology and Laboratory Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. · Department of Neurology, Georgetown University Medical Center, Washington, DC, USA. · Department of Neurology, University of Rochester Medical Center, Rochester, NY, USA. · Department of Neurology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA; Department of Psychiatry, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA. · Department of Neurology, Division of Neurogenetics, VA Puget Sound Health Care System, Seattle, WA, USA. · Institute for Neurodegenerative Disorders, New Haven, CT, USA. · Precision Medicine, Biogen, Cambridge, MA, USA. · Meta-Research Innovation Center at Stanford (METRICS), Stanford University, Stanford, CA, USA; Department of Medicine, Stanford Prevention Research Center, Stanford, CA, USA; Department of Health Research and Policy, Stanford University School of Medicine, Stanford, CA, USA; Department of Statistics, Stanford University School of Humanities and Sciences, Stanford, CA, USA. · Laboratory of Neurogenetics, National Institute on Aging, National Institutes of Health, Bethesda, MD, USA. Electronic address: · Pubmed 26271532
  • Department of Veteran Affairs Medical Center, San Francisco, California, USA. · Department of Radiology and Biomedical Imaging, University of California, San Francisco, California, USA. · Department of Biostatistics, College of Public Health, University of Iowa, Iowa City, Iowa, USA. · Department of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, Illinois, USA. · Institute for Neurodegenerative Disorders (IND) and Molecular Neuroimaging, LLC (MNI), New Haven, Connecticut, USA. · Baylor College of Medicine, Houston, Texas, USA. · Department of Neurology, University of California, San Francisco, CA, USA. · Emory University, Atlanta, Georgia, USA. · University of Tuebingen, Tuebingen, Germany. · Innsbruck Medical University, Innsbruck, Austria. · Paracelsus-Elena Klinik, Kassel, Germany. · Johns Hopkins University, Baltimore, Maryland, USA. · Macquarie University, Sydney, Australia. · Pubmed 26260437
  • Northwestern University Feinberg School of Medicine, Chicago, IL, USA. · The University of Iowa, Iowa City, IA, USA. · The University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA. · Institute for Neurodegenerative Disorders, New Haven, CT, USA. · Charitable Hertie Foundation, Frankfurt/Main, Germany. · Hephata-Klinik, Hephata Hessisches Diakoniezentrum e. V. · Innsbruck Medical University, Innsbruck, Austria. · McGill University, Montréal, Québec, Canada. · Massachusetts General Hospital, Boston, MA, USA. · UAB School of Medicine, Birmingham, AL, USA. · Pubmed 26095202
2014
  • Institute for Neurodegenerative Disorders, New Haven, CT, USA. · Department of Biostatistics and Computational Biology, University of Rochester, Rochester, NY, USA. · Program for Regulatory Science & Medicine (PRSM), Georgetown University, Washington, D.C., USA. · Pubmed 25062961
  • From the Institute for Neurodegenerative Disorders (D.J., J.S., K.M.), New Haven, CT · Parkinson's Disease and Movement Disorders Center (M.S.), Department of Neurology, University of Pennsylvania, Philadelphia · Department of Biostatistics and Computational Biology (S.E., D.O.), University of Rochester, NY · and Avid Radiopharmaceuticals (A.S.), Philadelphia, PA. · Pubmed 25298306
2013
  • 1 Critical Path Institute, Coalition Against Major Diseases, Tucson, AZ, USA. · 2 Independent science writer, Elverson, PA, USA. · 3 Alzheimer's Association, Chicago, IL, USA. · 4 Pfizer Inc, New London, CT, USA. · 5 Arizona State University, Phoenix, AZ, USA. · 6 Boehringer Ingelheim Pharmaceuticals Inc, Ridgefield, CT, USA. · 7 Mayo Clinic, Rochester, MN, USA. · 8 Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA. · 9 Eisai Inc, Woodcliff Lake, NJ, USA. · 10 Institute for Neurodegenerative Disorders, New Haven, CT, USA. · 11 Metrum Research Group, Tariffville, CT, USA. · Current affiliation: Synergia Consulting, MI, USA. · 12 Johnson & Johnson, Raritan, NJ, USA. · 13 Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA. · 14 US Food and Drug Administration, Silver Spring, MD, USA. · 15 USAgainst Alzheimer's, Washington, DC, USA. · 16 European Medicines Agency (EMA), London, UK. · Pubmed 30235546
2012
  • Institute for Neurodegenerative Disorders, New Haven, CT, USA. · Pubmed 23026362
Miscellaneous cities in USA
2019
  • Northwestern University Feinberg School of Medicine, USA. Electronic address: · The University of Iowa, USA. Electronic address: · The University of Iowa, USA. Electronic address: · The University of Pennsylvania, USA. Electronic address: · University of California San Francisco, USA. Electronic address: · University of Rochester Medical Center, USA. Electronic address: · Center of Parkinsonism and Movement Disorders Paracelsus-Elena Klinik Kassel and University Medical Center Goettingen, Germany. Electronic address: · University of California San Diego, USA. Electronic address: · TransThera Consulting, USA. Electronic address: · Indiana University, USA. Electronic address: · University of Pittsburgh, USA. Electronic address: · The University of Pennsylvania, USA. Electronic address: · University of Rochester Medical Center, USA. Electronic address: · University of Rochester Medical Center, USA. Electronic address: · Clinical Trial Coordination Center, University of Rochester Medical Center, USA. Electronic address: · Michael J Fox Foundation, USA. · Institute for Neurodegenerative Disorders, USA. Electronic address: · Michael J Fox Foundation, USA. Electronic address: · Michael J Fox Foundation, USA. Electronic address: · Michael J Fox Foundation, USA. Electronic address: · Institute for Neurodegenerative Disorders, USA. Electronic address: · Harvard Medical School, Beth Israel Deaconess Medical Center, Parkinson's Disease and Movement Disorders Center, Director of the HDSA Center of Excellence, USA. Electronic address: · Denali Therapeutics, USA. Electronic address: · Northwestern University Feinberg School of Medicine, USA. Electronic address: · Pubmed 30738748
Yale University
2017
  • Department of Physiology, Emory University, 615 Michael Street, 605L Whitehead Biomedical Res. Bldg., Atlanta, GA, 30322, USA. · Department of Biostatistics, University of Iowa, 145 N. Riverside Drive, 100 CPHB, Iowa City, Iowa, 52242, USA. · BioLegend, Inc., 180 Rustcraft Rd # 140, Dedham, Massachusetts, 02026, USA. · Paracelsus-Elena-Klinik, 34128 Kassel, Kassel, Germany. · Georg-August University Medical Center Goettingen, 37075, Goettingen, Germany. · Program in Neuroscience and Division of Neurology, The Ottawa Hospital, University of Ottawa Brain & Mind Institute, 451 Smyth Road, Room 1412, Ottawa, K1H 8M5, Canada. · Follow the Molecule, 143 Voyage Mall, Marina del Rey, CA, 90292, USA. · PAREXEL International, Early Phase Unit, 1560 E. Chevy Chase Drive, Suite 140, Glendale, CA, 91206, USA. · Research Programs, The Michael J. Fox Foundation for Parkinson's Research, 69 7th Avenue, 498, New York, NY, 10018, USA. · Yale-New Haven Hospital, 20 York Street, New Haven, CT, 06510, USA. · Nell Hodgson Woodruff School of Nursing, Emory University, 1520 Clifton Rd, Atlanta, GA, 30322, USA. · Department of Physiology, Emory University, 615 Michael Street, 605L Whitehead Biomedical Res. Bldg., Atlanta, GA, 30322, USA. · Pubmed 28821274
2012
  • Yale University School of Medicine, New Haven, Connecticut 06519, USA. · Pubmed 22609082
Helmholtz-Gemeinschaft
2016
  • Department of Neurology, Montreal General Hospital, Montreal, Quebec, Canada. Electronic address: · Department of Neurodegeneration, Hertie-Institute for Clinical Brain Research and German Center for Neurodegenerative Diseases, Tuebingen, Germany. · The Parkinson's Disease and Movement Disorders Center, Department of Neurology, Mayo Clinic, Scottsdale. · Department of Neurology, Radboud university medical center, Donders Institute for Brain, Cognition and Behaviour, Nijmegen, Netherlands. · Xuanwu Hospital of Capitol of Medical University, Beijing, Peoples Republic of China. · Department of Neurology, Christian-Albrechts University, Kiel, Germany. · Rush University Medical Center, Chicago, IL, USA. · Neuroscience Research Australia and University of New South Wales, Randwick, Australia. · Department of Epidemiology and Biostatistics, McGill University, Montreal, Quebec, Canada. · Division of Neurology, Toronto Western Hospital, Toronto, Ontario, Canada. · Department of Neurosciences, UC San Diego, La Jolla, California, USA. · Department of Neurodegeneration, Hertie-Institute for Clinical Brain Research and German Center for Neurodegenerative Diseases, Tuebingen, Germany; Institute for Neurodegenerative Disorders, New Haven, CT, USA. · Department of Neurology, Philipps University of Marburg, Marburg, Germany. · Department of Neurology, The Mount Sinai Hospital, New York, NY, USA. · Department of Neurology, Innsbruck Medical University, Innsbruck, Austria. · Penn Neurological Institute, Philadelphia, Pennsylvania, USA. · Pubmed 27302120
2014
  • Department of Neurodegeneration, Hertie Institute for Clinical Brain Research and German Center of Neurodegenerative Diseases, Tuebingen, Germany. · Pubmed 24619848
2012
  • Department of Neurodegeneration, Hertie Institute of Clinical Brain Research and German Center of Neurodegenerative Diseases, University of Tübingen, Tübingen, Germany. · Pubmed 22508284
University of Tubingen
2016
  • Department of Neurology, Montreal General Hospital, Montreal, Quebec, Canada. Electronic address: · Department of Neurodegeneration, Hertie-Institute for Clinical Brain Research and German Center for Neurodegenerative Diseases, Tuebingen, Germany. · The Parkinson's Disease and Movement Disorders Center, Department of Neurology, Mayo Clinic, Scottsdale. · Department of Neurology, Radboud university medical center, Donders Institute for Brain, Cognition and Behaviour, Nijmegen, Netherlands. · Xuanwu Hospital of Capitol of Medical University, Beijing, Peoples Republic of China. · Department of Neurology, Christian-Albrechts University, Kiel, Germany. · Rush University Medical Center, Chicago, IL, USA. · Neuroscience Research Australia and University of New South Wales, Randwick, Australia. · Department of Epidemiology and Biostatistics, McGill University, Montreal, Quebec, Canada. · Division of Neurology, Toronto Western Hospital, Toronto, Ontario, Canada. · Department of Neurosciences, UC San Diego, La Jolla, California, USA. · Department of Neurodegeneration, Hertie-Institute for Clinical Brain Research and German Center for Neurodegenerative Diseases, Tuebingen, Germany; Institute for Neurodegenerative Disorders, New Haven, CT, USA. · Department of Neurology, Philipps University of Marburg, Marburg, Germany. · Department of Neurology, The Mount Sinai Hospital, New York, NY, USA. · Department of Neurology, Innsbruck Medical University, Innsbruck, Austria. · Penn Neurological Institute, Philadelphia, Pennsylvania, USA. · Pubmed 27302120
2014
  • Department of Neurodegeneration, Hertie Institute for Clinical Brain Research and German Center of Neurodegenerative Diseases, Tuebingen, Germany. · Pubmed 24619848
2012
  • Department of Neurodegeneration, Hertie Institute of Clinical Brain Research and German Center of Neurodegenerative Diseases, University of Tübingen, Tübingen, Germany. · Pubmed 22508284
Unspecified
2016
  • Northwestern University Feinberg School of Medicine, United States. Electronic address: · The University of Iowa, United States. Electronic address: · The University of Iowa, United States. Electronic address: · Institute for Neurodegenerative Disorders, United States. Electronic address: · University of California San Francisco, United States. Electronic address: · Institute for Neurodegenerative Disorders, United States. Electronic address: · Pubmed 27132498
Georgetown University
2015
  • 1 Neurogenomics Lab and Parkinson Personalized Medicine Program, Harvard Medical School and Brigham and Women's Hospital, Cambridge, MA 02139, USA 2 Department of Neurology, Massachusetts General Hospital, Boston, MA 02114, USA. · 3 Department of Biostatistics and Computational Biology, University of Rochester Medical Center, Rochester, NY 14642, USA. · 1 Neurogenomics Lab and Parkinson Personalized Medicine Program, Harvard Medical School and Brigham and Women's Hospital, Cambridge, MA 02139, USA 4 Ann Romney Centre for Neurologic Diseases, Brigham and Women's Hospital, Boston, MA 02115, USA. · 1 Neurogenomics Lab and Parkinson Personalized Medicine Program, Harvard Medical School and Brigham and Women's Hospital, Cambridge, MA 02139, USA 4 Ann Romney Centre for Neurologic Diseases, Brigham and Women's Hospital, Boston, MA 02115, USA 5 Biomarkers Program, Harvard NeuroDiscovery Center, Boston, MA 02115, USA. · 2 Department of Neurology, Massachusetts General Hospital, Boston, MA 02114, USA. · 2 Department of Neurology, Massachusetts General Hospital, Boston, MA 02114, USA 6 Department of Psychiatry, Massachusetts General Hospital, Boston, MA 02114, USA. · 7 Department of Neurology, Brigham and Women's Hospital, Boston, MA 02115, USA. · 2 Department of Neurology, Massachusetts General Hospital, Boston, MA 02114, USA 5 Biomarkers Program, Harvard NeuroDiscovery Center, Boston, MA 02115, USA. · 4 Ann Romney Centre for Neurologic Diseases, Brigham and Women's Hospital, Boston, MA 02115, USA 7 Department of Neurology, Brigham and Women's Hospital, Boston, MA 02115, USA. · 8 Program for Regulatory Science and Medicine, Department of Neurology, Georgetown University, Washington, DC 20007, USA. · 4 Ann Romney Centre for Neurologic Diseases, Brigham and Women's Hospital, Boston, MA 02115, USA 5 Biomarkers Program, Harvard NeuroDiscovery Center, Boston, MA 02115, USA. · 9 Institute for Neurodegenerative Disorders, New Haven, CT 06510, USA. · 10 Program in Neuroscience, Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Ontario K1H8M5, Canada. · 1 Neurogenomics Lab and Parkinson Personalized Medicine Program, Harvard Medical School and Brigham and Women's Hospital, Cambridge, MA 02139, USA 2 Department of Neurology, Massachusetts General Hospital, Boston, MA 02114, USA 4 Ann Romney Centre for Neurologic Diseases, Brigham and Women's Hospital, Boston, MA 02115, USA 5 Biomarkers Program, Harvard NeuroDiscovery Center, Boston, MA 02115, USA 7 Department of Neurology, Brigham and Women's Hospital, Boston, MA 02115, USA · Pubmed 26220939
Miscellaneous cities in Connecticut
2015
  • 1 Division of Brain Sciences, Imperial College London, South Kensington Campus, London, SW7 2AZ, UK. · 2 Institute for Neurodegenerative Disorders, 60 Temple Street, Connecticut 06510, USA. · 3 Department of Nuclear Medicine and PET Centre, Aarhus University Hospital, Nørrebrogade 44, 8000 Aarhus, Denmark. · 1 Division of Brain Sciences, Imperial College London, South Kensington Campus, London, SW7 2AZ, UK 3 Department of Nuclear Medicine and PET Centre, Aarhus University Hospital, Nørrebrogade 44, 8000 Aarhus, Denmark. · 1 Division of Brain Sciences, Imperial College London, South Kensington Campus, London, SW7 2AZ, UK 3 Department of Nuclear Medicine and PET Centre, Aarhus University Hospital, Nørrebrogade 44, 8000 Aarhus, Denmark · Pubmed 26209314
University of Rochester
2014
  • From the Institute for Neurodegenerative Disorders (K.M., J.S., D.J.), University of Rochester (S.E., D.O.), Rochester, NY · Georgetown University (I.S.), Washington, DC · University of Toronto (A.E.L.) · and Western University (C.H.), London, Ontario, Canada. · Pubmed 24759846
University of Florida
2014
  • Departments of Neurology, Neurosurgery and Psychiatry, McKnight Brain Institute, University of Florida, 100 S Newell Dr Rm-L3-101, Gainesville, 32611 FL USA. · Pubmed 26788334
8 Other Locations Show
Yearly article counts 1371091066521
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.